Jailendra Singh
Stock Analyst at Truist Securities
(0.82)
# 4,068
Out of 5,241 analysts
199
Total ratings
24.32%
Success rate
-25.14%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DOCS Doximity | Reiterates: Hold | $29 → $19 | $19.58 | -2.96% | 12 | May 14, 2026 | |
| ASTH Astrana Health | Maintains: Buy | $38 → $47 | $38.98 | +20.57% | 7 | May 14, 2026 | |
| PGNY Progyny | Maintains: Buy | $28 → $30 | $24.05 | +24.74% | 12 | May 11, 2026 | |
| PHR Phreesia | Downgrades: Hold | $24 → $11 | $9.08 | +21.15% | 8 | Mar 31, 2026 | |
| VEEV Veeva Systems | Reiterates: Buy | $275 → $262 | $163.85 | +59.90% | 8 | Mar 5, 2026 | |
| PRVA Privia Health Group | Maintains: Buy | $31 → $33 | $23.69 | +39.30% | 9 | Mar 2, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $6 | $3.90 | +53.85% | 9 | Feb 26, 2026 | |
| HIMS Hims & Hers Health | Reiterates: Hold | $37 → $18 | $22.29 | -19.25% | 12 | Feb 24, 2026 | |
| IQV IQVIA Holdings | Maintains: Buy | $290 → $245 | $172.81 | +41.77% | 19 | Feb 19, 2026 | |
| WAY Waystar Holding | Maintains: Buy | $51 → $38 | $18.55 | +104.85% | 4 | Feb 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $555 → $539 | $420.67 | +28.13% | 7 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $52 | $36.02 | +44.36% | 1 | Jan 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $231 → $222 | $113.78 | +95.11% | 11 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $12 → $22 | $13.58 | +62.00% | 1 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $48 | $54.71 | -12.26% | 1 | Jun 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $10 → $9 | $6.35 | +41.73% | 16 | May 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $6.5 → $5.5 | $2.50 | +120.00% | 12 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $12 → $7.5 | $7.76 | -3.35% | 7 | Apr 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $14 | $10.50 | +33.33% | 1 | Jul 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $160 → $163 | $86.80 | +87.21% | 8 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $13 | $1.79 | +626.26% | 11 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $30 → $24 | $0.8406 | +2,755.10% | 2 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $14 → $4 | $1.06 | +277.36% | 4 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $58 | $199.77 | -70.97% | 2 | Feb 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $90 → $45 | $0.8623 | +5,118.60% | 7 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $230 → $333 | $775.97 | -57.09% | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $9 | $3.39 | +165.49% | 2 | May 19, 2021 |
Doximity
May 14, 2026
Reiterates: Hold
Price Target: $29 → $19
Current: $19.58
Upside: -2.96%
Astrana Health
May 14, 2026
Maintains: Buy
Price Target: $38 → $47
Current: $38.98
Upside: +20.57%
Progyny
May 11, 2026
Maintains: Buy
Price Target: $28 → $30
Current: $24.05
Upside: +24.74%
Phreesia
Mar 31, 2026
Downgrades: Hold
Price Target: $24 → $11
Current: $9.08
Upside: +21.15%
Veeva Systems
Mar 5, 2026
Reiterates: Buy
Price Target: $275 → $262
Current: $163.85
Upside: +59.90%
Privia Health Group
Mar 2, 2026
Maintains: Buy
Price Target: $31 → $33
Current: $23.69
Upside: +39.30%
Evolent Health
Feb 26, 2026
Maintains: Buy
Price Target: $10 → $6
Current: $3.90
Upside: +53.85%
Hims & Hers Health
Feb 24, 2026
Reiterates: Hold
Price Target: $37 → $18
Current: $22.29
Upside: -19.25%
IQVIA Holdings
Feb 19, 2026
Maintains: Buy
Price Target: $290 → $245
Current: $172.81
Upside: +41.77%
Waystar Holding
Feb 18, 2026
Maintains: Buy
Price Target: $51 → $38
Current: $18.55
Upside: +104.85%
Feb 11, 2026
Maintains: Hold
Price Target: $555 → $539
Current: $420.67
Upside: +28.13%
Jan 12, 2026
Initiates: Buy
Price Target: $52
Current: $36.02
Upside: +44.36%
Jan 8, 2026
Downgrades: Hold
Price Target: $231 → $222
Current: $113.78
Upside: +95.11%
Jan 8, 2026
Upgrades: Buy
Price Target: $12 → $22
Current: $13.58
Upside: +62.00%
Jun 16, 2025
Initiates: Buy
Price Target: $48
Current: $54.71
Upside: -12.26%
May 27, 2025
Maintains: Hold
Price Target: $10 → $9
Current: $6.35
Upside: +41.73%
Apr 10, 2025
Maintains: Hold
Price Target: $6.5 → $5.5
Current: $2.50
Upside: +120.00%
Apr 10, 2025
Maintains: Hold
Price Target: $12 → $7.5
Current: $7.76
Upside: -3.35%
Jul 2, 2024
Maintains: Buy
Price Target: $17 → $14
Current: $10.50
Upside: +33.33%
May 24, 2024
Maintains: Hold
Price Target: $160 → $163
Current: $86.80
Upside: +87.21%
May 4, 2022
Maintains: Neutral
Price Target: $16 → $13
Current: $1.79
Upside: +626.26%
Feb 24, 2022
Maintains: Neutral
Price Target: $30 → $24
Current: $0.8406
Upside: +2,755.10%
Feb 8, 2022
Downgrades: Neutral
Price Target: $14 → $4
Current: $1.06
Upside: +277.36%
Feb 4, 2022
Maintains: Neutral
Price Target: $60 → $58
Current: $199.77
Upside: -70.97%
Jan 7, 2022
Downgrades: Underperform
Price Target: $90 → $45
Current: $0.8623
Upside: +5,118.60%
Jan 7, 2022
Upgrades: Outperform
Price Target: $230 → $333
Current: $775.97
Upside: -57.09%
May 19, 2021
Maintains: Neutral
Price Target: $10 → $9
Current: $3.39
Upside: +165.49%